{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:46:45Z","timestamp":1785912405758,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jsat.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T14:39:24Z","timestamp":1508337564000},"page":"17-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Factors associated with naloxone administration in an opioid dependent sample"],"prefix":"10.1016","volume":"84","author":[{"given":"Shannon R.","family":"Kenney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2017.10.008_bb0005","author":"Center for Behavioral Health Statistics and Quality"},{"issue":"3","key":"10.1016\/j.jsat.2017.10.008_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2017.10.008_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal","volume":"158","author":"Coffin","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2017.10.008_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Nonrandomized intervention study of naloxone Coprescription for primary care patients receiving long-term opioid therapy for pain","volume":"165","author":"Coffin","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"13","key":"10.1016\/j.jsat.2017.10.008_bb0025","first-page":"1296","article-title":"Nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"2S","key":"10.1016\/j.jsat.2017.10.008_bb0030","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.japh.2016.11.007","article-title":"State legal innovations to encourage naloxone dispensing","volume":"57","author":"Davis","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"4","key":"10.1016\/j.jsat.2017.10.008_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/08897077.2016.1238431","article-title":"Co-prescribing naloxone does not increase liability risk","volume":"37","author":"Davis","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.10.008_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-297","article-title":"Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: A retrospective cohort study","volume":"14","author":"Doe-Simkins","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jsat.2017.10.008_bb0045","series-title":"Expanding access to naloxone in the United States","first-page":"989","volume":"52(10)","author":"Doyon","year":"2014"},{"key":"10.1016\/j.jsat.2017.10.008_bb0050","series-title":"Fall River's opioid overdose problem is getting worse","author":"Fraga","year":"2017"},{"key":"10.1016\/j.jsat.2017.10.008_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2016.03.024","article-title":"Opioid overdose and naloxone: The antidote to an epidemic?","volume":"163","author":"Green","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2017.10.008_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2105\/AJPH.2016.303062","article-title":"Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013","volume":"106","author":"Jones","year":"2016","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2017.10.008_bb0065","first-page":"1","article-title":"Injection drug users trained by overdose prevention programs: Responses to witnessed overdoses","author":"Lankenau","year":"2012","journal-title":"Journal of Community Health"},{"issue":"7","key":"10.1016\/j.jsat.2017.10.008_bb0070","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.jsat.2017.10.008_bb0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2017.10.008_bb0080","author":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2017.10.008_bb1000","unstructured":"Overdose Education and Naloxone Distribution (OEND) 1st Responder Naloxone Grants, December 2016, Massachusetts Department of Public Health, Retrieved from https:\/\/malegislature.gov\/Bills\/189\/SD2777.pdf, page 6."},{"issue":"3","key":"10.1016\/j.jsat.2017.10.008_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2005.04.012","article-title":"Heroin overdose among young injection drug users in San Francisco","volume":"80","author":"Ochoa","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2017.10.008_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2007.02.012","article-title":"Prescription opioid abuse among enrollees into methadone maintenance treatment","volume":"90","author":"Rosenblum","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.10.008_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2015.12.018","article-title":"Correlates of overdose risk perception among illicit opioid users","volume":"159","author":"Rowe","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2017.10.008_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2012.08.014","article-title":"Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs","volume":"128","author":"Silva","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"23","key":"10.1016\/j.jsat.2017.10.008_bb0105","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2017.10.008_bb0110","series-title":"Community management of opioid overdose","author":"World Heath Organization","year":"2014"},{"issue":"1","key":"10.1016\/j.jsat.2017.10.008_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0b013e3181e0364e","article-title":"How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on alcohol and related conditions","volume":"5","author":"Wu","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"12","key":"10.1016\/j.jsat.2017.10.008_bb0120","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1001\/jamainternmed.2014.5413","article-title":"Presentation of prescription and nonprescription opioid overdoses to US emergency departments","volume":"174","author":"Yokell","year":"2014","journal-title":"JAMA Internal Medicine"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721730301X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721730301X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:46:21Z","timestamp":1760039181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054721730301X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":25,"alternative-id":["S074054721730301X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.10.008","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with naloxone administration in an opioid dependent sample","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}